Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT)

The Ohio State University

Status

Completed

Conditions

Stage IIIB Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Stage IVA Lung Cancer AJCC v8

Extensive Stage Lung Small Cell Carcinoma

Advanced Lung Carcinoma

Stage IVB Lung Cancer AJCC v8

Unresectable Lung Non-Small Cell Carcinoma

Unresectable Lung Carcinoma

Stage IV Lung Cancer AJCC v8

Treatments

Other: Quality-of-Life Assessment

Procedure: Relaxation Therapy

Other: Questionnaire Administration

Procedure: Physical Therapy

Study type

Interventional

Funder types

Other

NIH

Identifiers

NCT04229381

OSU-19115

NCI-2019-04722 (Registry Identifier)

R03AG064374 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This trial studies how well physical therapy and progressive muscle relaxation works in improving physical performance and mood in older patients with stage IIIA-B or IV lung cancer who are undergoing treatment. Improving physical performance and mood may help older patients maintain an independent lifestyle by helping to improve their resilience, the ability to bounce back to normal functioning after a stressor or intervening health event such as treatment or disease progression. Giving physical therapy and progressive muscle relaxation may work in improving symptoms and quality of life in patients with lung cancer.

Full description

PRIMARY OBJECTIVES:

I. To assess the feasibility of a novel, weekly supervised virtual health-assisted physical therapy plus relaxation intervention delivered to older adults with advanced thoracic malignancy (N=20).

OUTLINE:

Patients participate physical therapy sessions consisting of cardiovascular and resistance training exercises in person or online and also undergo progressive muscle relaxation sessions once weekly for up to 12 weeks.

After completion of study therapy, patients are followed up at 24 weeks, and then periodically for up to 24 months.

Enrollment

18 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosed with advanced lung cancer: unresectable stage IIIA, IIIB, or stage IV non-small cell lung cancer (NSCLC) or extensive stage small cell lung cancer (SCLC).
Intent to receive treatment from the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic.
Willingness to participate and adhere to the study intervention program.
Ability to understand and willingness to sign an informed consent document (or indicate approval or disapproval by another means).

Exclusion criteria

Prisoners are excluded from participation.
There is NO exclusion criteria pertaining to Eastern Cooperative Oncology Group (ECOG) performance status, laboratory values, prior cancer diagnoses, presence of comorbidities or brain metastases.